QBIO (Q BioMed) Net Margin %: 0.00% (As of Feb. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Q BioMed Net Margin %?

Q BioMed QBIO -99.00% Net Margin % is 0.00% as of Feb. 2023.

Net margin is calculated as Net Income divided by its Revenue. Q BioMed's Net Income for the three months ended in Feb. 2023 was $-0.72 Mil. Q BioMed's Revenue for the three months ended in Feb. 2023 was $0.00 Mil. Therefore, Q BioMed's net margin for the quarter that ended in Feb. 2023 was 0.00%.

The historical rank and industry rank for Q BioMed's Net Margin % or its related term are showing as below:


QBIO's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.635
* Ranked among companies with meaningful Net Margin % only.

Q BioMed  (OTCPK:QBIO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Q BioMed Net Margin % Related Terms


Q BioMed Net Margin % Historical Data

* Premium members only.

The historical data trend for Q BioMed's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q BioMed Net Margin % Chart

Q BioMed Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -44,973.33 -4,204.59 -722.54

Q BioMed Quarterly Data
May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,052.00 -747.65 -3,057.69 17,707.69 0.00

QBIO vs RGMP, CALA, PPCB: Net Margin % Comparison

For the Biotechnology subindustry, Q BioMed's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q BioMed Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q BioMed's Net Margin % distribution charts can be found below:

* The bar in red indicates where Q BioMed's Net Margin % falls into.



Q BioMed Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Q BioMed's Net Margin for the fiscal year that ended in Nov. 2022 is calculated as

Net Margin=Net Income (A: Nov. 2022 )/Revenue (A: Nov. 2022 )
=-2.052/0.284
=-722.54 %

Q BioMed's Net Margin for the quarter that ended in Feb. 2023 is calculated as

Net Margin=Net Income (Q: Feb. 2023 )/Revenue (Q: Feb. 2023 )
=-0.722/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Q BioMed (QBIO) has a Net Margin % of 0.00% as of Feb. 2023. Net margin is the ratio of total net income to net sales. View historical data on Q BioMed and its competitors.
Is Q BioMed's Net Margin % too high?
Q BioMed's current Net Margin % is 0.00%.
How does Q BioMed's Net Margin % compare to RGMP and CALA?
Q BioMed's Net Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Q BioMed and its competitors. Q BioMed's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q BioMed stock overvalued right now?
Q BioMed (QBIO) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Q BioMed (QBIO), the current Net Margin % is 0.00% as of Feb. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q BioMed Business Description

Address c/o Ortoli Rosenstadt LLP, 366 Madison Avenue, 3rd Floor, New York, NY, USA, 10017
Q BioMed Inc is a biotech acceleration and commercial stage company. It is focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. The company provides these target assets the strategic resources, developmental support, and expansion capital needed to ensure customers meet their developmental potential, enabling them to provide products to patients in need.